Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Endocrinology

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE-07-0267PMID 17911404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fibroblast growth factor (FGF)23 in patients with acromegaly.

  2007influential reference
• Regulation of fibroblast growth factor-23 in chronic kidney disease.

  2007cited by this paper
• Klotho converts canonical FGF receptor into a specific receptor for FGF23

  2006influential reference
• A Novel Recessive Mutation in Fibroblast Growth Factor-23 Causes Familial Tumoral Calcinosis

  2006cited by this paper
• Regulation of Fibroblast Growth Factor-23 Signaling by Klotho*

  2006cited by this paper
• Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism

  2006cited by this paper
• DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis

  2006cited by this paper
• Regulation of parathyroid function in chronic kidney disease (CKD)

  2006cited by this paper
• Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients.

  2005influential reference
• An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

  2005cited by this paper
• Fibroblast growth factor-23 is regulated by 1alpha,25-dihydroxyvitamin D.

  2005cited by this paper
• Intravenous Calcitriol Therapy Increases Serum Concentrations of Fibroblast Growth Factor-23 in Dialysis Patients with Secondary Hyperparathyroidism

  2005cited by this paper
• Vitamin D and phosphate regulate fibroblast growth factor-23 in K-562 cells.

  2005cited by this paper
• Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

  2005influential reference
• A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.

  2005cited by this paper
• Fibroblast Growth Factor‐23 Is Regulated by 1α,25‐Dihydroxyvitamin D

  2005cited by this paper
• Elevated fibroblast growth factor‐23 in hypophosphatemic linear nevus sebaceous syndrome

  2005cited by this paper
• Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.

  2004cited by this paper
• FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

  2004cited by this paper
• FGF-23 is elevated by chronic hyperphosphatemia.

  2004cited by this paper
• Bone as a source of FGF23: regulation by phosphate?

  2004cited by this paper
• Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.

  2004influential reference
• Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

  2004influential reference
• FGF-23 in patients with end-stage renal disease on hemodialysis.

  2004influential reference
• Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.

  2004cited by this paper
• Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

  2004influential reference
• FGF‐23 Is a Potent Regulator of Vitamin D Metabolism and Phosphate Homeostasis

  2003cited by this paper
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Regulation of Fibroblastic Growth Factor 23 Expression but Not Degradation by PHEX*

  2003cited by this paper
• FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.

  2003influential reference
• Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.

  2003influential reference
• Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

  2003cited by this paper
• Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

  2003influential reference
• Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia.

  2002influential reference
• 25-hydroxyvitamin D3-1α-hydroxylase expression in normal and pathological parathyroid glands

  2002influential reference
• Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

  2002cited by this paper
• 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.

  2002influential reference
• The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.

  2001cited by this paper
• Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.

  2001cited by this paper
• The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate Wasting

  2001influential reference
• Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

  2001influential reference
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

  2000cited by this paper
• Characterization of the Human Megalin/LRP-2 Promoter In Vitro and in Primary Parathyroid Cells

  1998cited by this paper
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method

  year unknowncited by this paper

• Metabolic Bone Disease in Captive Flying Foxes: A Conceptual Framework and Future Perspectives

  2026cites this paper
• The Potential Role of Vitamin D in the Pterygium Pathophysiology—A Possible New Therapeutic Perspective and Narrative Review

  2025cites this paper
• Current Controversies on Adequate Circulating Vitamin D Levels in CKD

  2025cites this paper
• Vitamin D and Vitamin D Analogues in Hemodialysis Patients: A Review of the Literature

  2025cites this paper
• An update on investigation and management of renal bone disease.

  2025cites this paper
• Leptin regulates parathyroid hormone secretion through CaSR‐ERK1/2 signaling

  2025cites this paper
• Intestinal Cyp24a1 regulates vitamin D locally independent of systemic regulation by renal Cyp24a1 in mice

  2024cites this paper
• The transcription factor BBX regulates phosphate homeostasis through the modulation of FGF23

  2024cites this paper
• Endocrine fibroblast growth factors in domestic animals.

  2024cites this paper
• Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs

  2024cites this paper
• The Effect of Periodontitis on Fibroblast Growth Factor 23 Levels in Predialysis Chronic Kidney Disease Patients

  2024cites this paper
• Vitamin D–Parathyroid Hormone–Fibroblast Growth Factor 23 Axis and Cardiac Remodeling

  2024cites this paper
• Anemia and Mineral Bone Disorder in Kidney Disease Patients: The Role of FGF-23 and Other Related Factors

  2024cites this paper
• Fibroblast Growth Factor 23 - a review with particular reference to the physiology and pathophysiology of phosphate homeostasis in the cat.

  2024cites this paper
• Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric.

  2024cites this paper
• Focusing on Phosphorus Loads: From Healthy People to Chronic Kidney Disease

  2023cites this paper
• Kidney clearance of fibroblast growth factor-23 in humans

  2023cites this paper
• Intact FGF23 concentration in healthy infants, children, and adolescents, and diagnostic usefulness in patients with X-linked hypophosphatemic rickets

  2023cites this paper
• Vitamin D and Its Analogues: From Differences in Molecular Mechanisms to Potential Benefits of Adapted Use in the Treatment of Alzheimer’s Disease

  2023cites this paper
• Shift in Calcium from Peripheral Bone to Axial Bone after Tumor Resection in Patients with Tumor-Induced Osteomalcia.

  2023cites this paper
• The Mechanosensory Role of Osteocytes and Implications for Bone Health and Disease States

  2022cites this paper
• SHORT COMMUNICATION: A potential new biomarker to monitor the phosphorus balance in dry dairy cows

  2022cites this paper
• Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect

  2022cites this paper
• Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease

  2022cites this paper
• Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside

  2022cites this paper
• COVID-19 infection and metabolic comorbidities: Mitigating role of nutritional sufficiency and drug – nutraceutical combinations of vitamin D

  2022cites this paper
• Calcium Transport in the Kidney and Disease Processes

  2022influential citation
• Hyperparathyroidism in a Large Cohort of Chinese Patients with Tumor-Induced Osteomalacia.

  2022cites this paper
• Calcium, phosphate, PTH, vitamin D, and FGF-23 in CKD-mineral and bone disorder

  2022cites this paper
• Role of endothelial cells in vascular calcification

  2022cites this paper
• Association Between Uremic Pruritus and Serum Level of Fibroblast Growth Factor 23 in Hemodialysis Patients in North of Iran: An Observational Study

  2022cites this paper
• New concepts in phosphorus homeostasis and its impact on renal health with particular reference to the cat.

  2022cites this paper
• The Role of DMP1 in CKD-MBD

  2021cites this paper
• A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 1: Physiology of calcium handling.

  2021cites this paper
• Non-classical Vitamin D Actions for Renal Protection

  2021cites this paper
• Osteodystrophy in Children with Urolithiasis Caused by Primary Hyperparathyroidism

  2021cites this paper
• Osteoporosis associated with chronic kidney disease

  2021cites this paper
• The Saga of Endocrine FGFs

  2021cites this paper
• Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management

  2021cites this paper
• ESKD Complications: CKD-MBD

  2021cites this paper
• A feline-focused review of chronic kidney disease-mineral and bone disorders - Part 1: Physiology of calcium handling.

  2021cites this paper
• Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.

  2021cites this paper
• Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease

  2021cites this paper
• An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

  2021cites this paper
• Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer

  2021cites this paper
• C-terminal and intact FGF23 in kidney transplant recipients and their associations with overall graft survival

  2021cites this paper
• Upstream Regulators of Fibroblast Growth Factor 23

  2021cites this paper
• Serum intact fibroblast growth factor 23 in healthy paediatric population

  2021cites this paper
• Higher maternal parathyroid hormone concentration at delivery is not associated with smaller newborn size

  2021cites this paper
• Dietary phosphorus restriction affects bone metabolism, vitamin D metabolism and rumen fermentation traits in sheep.

  2020cites this paper
• miR-129 Blocks Secondary Hyperparathyroidism-Inducing Fgf23/αKlotho Signaling in Mice with Chronic Kidney Disease.

  2020cites this paper
• FGF23 signalling and physiology.

  2020cites this paper
• Identification of the cleavage sites leading to the shed forms of human and mouse anti-aging and cognition-enhancing protein Klotho

  2020cites this paper
• Clinical Potential of Targeting Fibroblast Growth Factor‐23 and αKlotho in the Treatment of Uremic Cardiomyopathy

  2020cites this paper
• Diabetes Mellitus and Vitamin D Deficiency: Comparable Effect on Survival and a Deadly Association after a Myocardial Infarction

  2020cites this paper
• Fibroblast Growth Factor Receptor 4 Deficiency Mediates Airway Inflammation in the Adult Healthy Lung?

  2020cites this paper
• Relationship between GFR, intact PTH, oxidized PTH, non‐oxidized PTH as well as FGF23 in patients with CKD

  2020cites this paper
• Calciphylaxis associated with the fibroblast growth factor receptor inhibitor erdafitinib

  2020cites this paper
• FGF23 and Klotho in Chronic Kidney Disease

  2020cites this paper
• Genetic disorders caused by mutations in the parathyroid hormone/parathyroid hormone–related peptide receptor, its ligands, and downstream effector molecules

  2020cites this paper
• Parathyroid hormone molecular biology

  2020cites this paper
• Parathyroid Hormones

  2020cites this paper
• Phosphorus

  2020cites this paper
• Relation Between PTH and Biochemical Markers of MBD

  2020cites this paper
• Parathyroid Cell Proliferation in Secondary Hyperparathyroidism of Chronic Kidney Disease

  2020cites this paper
• Phosphate Metabolism in Health and Disease

  2020cites this paper
• Symposium review: Transition cow calcium homeostasis-Health effects of hypocalcemia and strategies for prevention.

  2020cites this paper
• Renal Osteodystrophy and Bone Biopsy

  2020cites this paper
• Impact of altered dietary calcium–phosphorus ratio caused by high-phosphorus diets in a rat chronic kidney disease (CKD) model created by partial ligation of the renal arteries

  2020cites this paper
• Parathyroid Glands in Chronic Kidney Disease

  2020cites this paper
• Post‐transcriptional mechanisms regulating parathyroid hormone gene expression in secondary hyperparathyroidism

  2020cites this paper
• Fibroblast Growth Factor-23 and Matrix Extracellular Phosphoglycoprotein Levels in Healthy Children and, Pregnant and Puerperal Women

  2020cites this paper
• Review: Regulation of gastrointestinal and renal transport of calcium and phosphorus in ruminants.

  2020cites this paper
• Phenotypes and pathways: Working toward an integrated skeletal biology in biological anthropology

  2020cites this paper
• Bone: Functions, Structure and Physiology

  2020cites this paper
• Hypocalcaemia following denosumab in prostate cancer: A clinical review

  2020cites this paper
• Mineral Bone Abnormalities and Vascular Calcifications.

  2019cites this paper
• FGF23 and the PTH response to paricalcitol in chronic kidney disease

  2019cites this paper
• Possible roles of parathyroid hormone, 1.25(OH)2D3, and fibroblast growth factor 23 on genes controlling calcium metabolism across different tissues of the laying hen.

  2019cites this paper
• FGF23 expression is stimulated in transgenic α-Klotho longevity mouse model.

  2019cites this paper
• Hypoalbuminemia differently affects the serum bone turnover markers in hemodialysis patients

  2019cites this paper
• FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction.

  2019cites this paper
• Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.

  2019cites this paper
• Evolving concepts in the pathogenesis of uraemic cardiomyopathy

  2019cites this paper
• Chapter 2 Vitamin D and Renal Disease

  2019cites this paper
• FGF23 Synthesis and Activity

  2019cites this paper
• Secondary and Tertiary Hyperparathyroidism in Chronic Kidney Disease: An Endocrine and Renal Perspective

  2019cites this paper
• FGF23 at the crossroads of phosphate, iron economy and erythropoiesis

  2019cites this paper
• Vitamin D Metabolism Revised: Fall of Dogmas

  2019cites this paper
• Calcification of abdominal aorta in patients recently starting hemodialysis: A single-center experience from Egypt

  2019cites this paper
• Phosphorus Retention and Elevated FGF-23 in Chronic Kidney Disease

  2019cites this paper
• The Role of Fibroblast Growth Factor 23 in Inflammation and Anemia

  2019cites this paper
• FGF23 and Associated Disorders of Phosphate Wasting.

  2019cites this paper
• Regulation of fibroblast growth factor 23 (FGF23) in health and disease

  2019cites this paper
• Multifaceted Mechanisms of Vascular Calcification in Aging.

  2019cites this paper
• Role of Fibroblast Growth Factor 23 and Klotho Crosstalk in Idiopathic Pulmonary Fibrosis.

  2019cites this paper
• p38MAPK controls fibroblast growth factor 23 (FGF23) synthesis in UMR106-osteoblast-like cells and in IDG-SW3 osteocytes

  2019cites this paper
• Bone Perfusion Alterations in Chronic Kidney Disease

  2019cites this paper
• A control region near the fibroblast growth factor 23 gene mediates response to phosphate, 1,25(OH)2D3 and LPS in vivo.

  2019cites this paper
• Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients

  2019cites this paper